Scientists have discovered non-invasive biomarkers to detect transplant organ rejection, applicable across kidneys, livers, lungs, and hearts.
This breakthrough hints at a future blood test for early diagnosis of organ rejection, a tool that currently doesn’t exist. The study analyzed 54 datasets and identified 158 genes associated with rejection in all four organ types, offering a “unifying pan-organ molecular marker.”
This could lead to better transplant success rates and alleviate patient anxiety about organ rejection.